Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens
Author:
Affiliation:
1. Gastroenterology Department; Complejo Hospitalario de Toledo; Toledo Spain
2. Gastroenterology Department; Hospital del Bierzo; Ponferrada Spain
3. Universidad Jaume I; Castelló Spain
Publisher
Wiley
Subject
Infectious Diseases,Gastroenterology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hel.12452/fullpdf
Reference23 articles.
1. Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report;Malfertheiner;Gut,2012
2. III Spanish consensus conference on Helicobacter pylori infection;Gisbert;Gastroenterol Hepatol,2013
3. Optimized non-bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance;Molina-Infante;Gastroenterology,2013
4. Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection;Hsu;Antimicrob Agents Chemother,2014
5. Randomized clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice;McNicholl;Gut,2014
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The second Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland;European Journal of Gastroenterology & Hepatology;2024-05-29
2. Abundance and prevalence of ESBL coding genes in patients undergoing first line eradication therapy for Helicobacter pylori;PLOS ONE;2023-08-10
3. Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection;International Journal of Molecular Sciences;2023-07-20
4. Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial;Digestive and Liver Disease;2023-05
5. Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori : A whole‐genome sequencing‐based study in Southern China;Helicobacter;2022-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3